These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16137187)

  • 1. Is there a role for beta-adrenoceptor agonists in the management of acute lung injury and the acute respiratory distress syndrome?
    McAuley DF; Matthay MA
    Treat Respir Med; 2005; 4(5):297-307. PubMed ID: 16137187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bench-to-bedside review: beta2-Agonists and the acute respiratory distress syndrome.
    Perkins GD; McAuley DF; Richter A; Thickett DR; Gao F
    Crit Care; 2004 Feb; 8(1):25-32. PubMed ID: 14975042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury.
    McAuley DF; Frank JA; Fang X; Matthay MA
    Crit Care Med; 2004 Jul; 32(7):1470-6. PubMed ID: 15241090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta2 adrenergic agonists in acute lung injury? The heart of the matter.
    Lee JW
    Crit Care; 2009; 13(6):1011. PubMed ID: 20017898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled
    Sriram K; Insel MB; Insel PA
    Pharmacol Rev; 2021 Oct; 73(4):488-526. PubMed ID: 34795026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure.
    Atabai K; Ware LB; Snider ME; Koch P; Daniel B; Nuckton TJ; Matthay MA
    Intensive Care Med; 2002 Jun; 28(6):705-11. PubMed ID: 12107675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2 adrenergic agonist therapy may enhance alveolar epithelial repair in patients with acute lung injury.
    Matthay MA; Lee J
    Thorax; 2008 Mar; 63(3):189-90. PubMed ID: 18308954
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of treatments for patients with acute lung injury.
    Esper AM; Martin GS
    Expert Opin Investig Drugs; 2005 May; 14(5):633-45. PubMed ID: 15926869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular pharmacology of acute lung injury and acute respiratory distress syndrome.
    Groeneveld AB
    Vascul Pharmacol; 2002 Nov; 39(4-5):247-56. PubMed ID: 12747964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β2 agonist for the treatment of acute lung injury: a systematic review and meta-analysis.
    Singh B; Tiwari AK; Singh K; Singh SK; Ahmed A; Erwin PJ; Franco PM
    Respir Care; 2014 Feb; 59(2):288-96. PubMed ID: 23777655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of beta-receptor stimulation-induced improvement of acute lung injury and pulmonary edema.
    Groshaus HE; Manocha S; Walley KR; Russell JA
    Crit Care; 2004 Aug; 8(4):234-42. PubMed ID: 15312205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-2-adrenoceptor agonists as inhibitors of lung vascular permeability to radiolabelled transferrin in the adult respiratory distress syndrome in man.
    Basran GS; Hardy JG; Woo SP; Ramasubramanian R; Byrne AJ
    Eur J Nucl Med; 1986; 12(8):381-4. PubMed ID: 2878809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic agonist therapy as a potential treatment for acute lung injury.
    Matthay MA; Abraham E
    Am J Respir Crit Care Med; 2006 Feb; 173(3):254-5. PubMed ID: 16436367
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of inhaled prostacyclin in treating acute respiratory distress syndrome.
    Searcy RJ; Morales JR; Ferreira JA; Johnson DW
    Ther Adv Respir Dis; 2015 Dec; 9(6):302-12. PubMed ID: 26294418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alveolar epithelial fluid transport in acute lung injury: new insights.
    Sartori C; Matthay MA
    Eur Respir J; 2002 Nov; 20(5):1299-313. PubMed ID: 12449188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.
    Perkins GD; McAuley DF; Thickett DR; Gao F
    Am J Respir Crit Care Med; 2006 Feb; 173(3):281-7. PubMed ID: 16254268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-2-agonist treatment as a potential therapy for acute inhalational lung injury.
    Wiener-Kronish JP; Matthay MA
    Crit Care Med; 2006 Jun; 34(6):1841-2. PubMed ID: 16714996
    [No Abstract]   [Full Text] [Related]  

  • 18. Alveolar fluid clearance in patients with ARDS: does it make a difference?
    Matthay MA
    Chest; 2002 Dec; 122(6 Suppl):340S-343S. PubMed ID: 12475812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic strategies for acute lung injury induced by lung damaging agents: the potential role of growth factors as treatment options.
    Lindsay CD
    Hum Exp Toxicol; 2011 Jul; 30(7):701-24. PubMed ID: 20621953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating cofactors of acute lung injury 2005-2006: any closer to 'prime time'?
    Hotchkiss JR; Broccard AF
    Curr Opin Crit Care; 2007 Feb; 13(1):39-44. PubMed ID: 17198047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.